These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 29495008)

  • 1. Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis.
    Chen E; Qin X; Peng K; Xu X; Li W; Cheng X; Tang C; Cui Y; Wang Z; Liu T
    Cell Physiol Biochem; 2018; 45(5):1731-1746. PubMed ID: 29495008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the Prognosis and Therapeutic Value of the CXC Chemokine Family in Head and Neck Squamous Cell Carcinoma.
    Li Y; Wu T; Gong S; Zhou H; Yu L; Liang M; Shi R; Wu Z; Zhang J; Li S
    Front Oncol; 2020; 10():570736. PubMed ID: 33489879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer.
    Hozhabri H; Moghaddam MM; Moghaddam MM; Mohammadian A
    Sci Rep; 2022 Jun; 12(1):10374. PubMed ID: 35725915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioinformatics analysis of the role of CXC ligands in the microenvironment of head and neck tumor.
    Jing F; Wang J; Zhou L; Ning Y; Xu S; Zhu Y
    Aging (Albany NY); 2021 Jul; 13(13):17789-17817. PubMed ID: 34247149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.
    Wu HT; Liu J; Li GW; Shen JX; Huang YT
    Oncotarget; 2017 May; 8(22):36279-36288. PubMed ID: 28422733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXC chemokines located in the 4q21 region are up-regulated in breast cancer.
    Bièche I; Chavey C; Andrieu C; Busson M; Vacher S; Le Corre L; Guinebretière JM; Burlinchon S; Lidereau R; Lazennec G
    Endocr Relat Cancer; 2007 Dec; 14(4):1039-52. PubMed ID: 18045955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer.
    Xia H; Yu W; Liu M; Li H; Pang W; Wang L; Zhang Y
    Oncol Lett; 2019 Sep; 18(3):2985-2994. PubMed ID: 31452777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines.
    Sun X; Chen Q; Zhang L; Chen J; Zhang X
    Math Biosci Eng; 2021 Jul; 18(5):6262-6287. PubMed ID: 34517533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis.
    Wu C; Ma C; Yuan J; Zhou P
    Math Biosci Eng; 2021 Sep; 18(6):8201-8222. PubMed ID: 34814296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment.
    Zeng Q; Sun S; Li Y; Li X; Li Z; Liang H
    Front Oncol; 2019; 9():1555. PubMed ID: 32117786
    [No Abstract]   [Full Text] [Related]  

  • 11. Comprehensive analysis of the expression and prognostic value of CXC chemokines in colorectal cancer.
    Yu L; Yang X; Xu C; Sun J; Fang Z; Pan H; Han W
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107077. PubMed ID: 33068862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics identification of CCL8/21 as potential prognostic biomarkers in breast cancer microenvironment.
    Chen B; Zhang S; Li Q; Wu S; He H; Huang J
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33146700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and clinical significance of CXC chemokines in the glioblastoma microenvironment.
    Li C; Deng H; Zhou Y; Ye Y; Zhao S; Liang S; Cai S; Lin J; Tang Y; Wu Y
    Life Sci; 2020 Nov; 261():118486. PubMed ID: 32976881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of therapeutic targets and prognostic biomarkers among CXC chemokines in hepatocellular carcinoma microenvironment.
    Yin Z; Ma T; Chen S; Yu M
    Cancer Biomark; 2023; 36(3):231-250. PubMed ID: 36938723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive analysis of the expression and significance of CXCLs in human diffuse large B-cell lymphoma.
    Zhou X; Guo S; Shi Y
    Sci Rep; 2022 Feb; 12(1):2817. PubMed ID: 35181719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functions of CXC chemokines as biomarkers and potential therapeutic targets in the hepatocellular carcinoma microenvironment.
    Wang J; Zhang C; Chen X; Li Y; Li A; Liu D; Li F; Luo T
    Transl Cancer Res; 2021 May; 10(5):2169-2187. PubMed ID: 35116536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression Pattern and Prognostic Significance of Chemokines in Breast cancer: An Integrated Bioinformatics Analysis.
    Mehraj U; Alshehri B; Khan AA; Bhat AA; Bagga P; Wani NA; Mir MA
    Clin Breast Cancer; 2022 Aug; 22(6):567-578. PubMed ID: 35585016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer.
    Cheng L; Tan Z; Huang Z; Pan Y; Zhang W; Wang J
    Med Sci Monit; 2020 Aug; 26():e923673. PubMed ID: 32830194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.
    Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z
    Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
    Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
    Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.